Kilian Kelly
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Healthcare should be accessible for all: development of the ObServation Tool and Resource for Inclusive Communication in Healthcare (OSTRICH).
Journal: Disability and rehabilitation
Published: June 25, 2026
Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.
Journal: Stem cell reports
Published: November 26, 2025
Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.
Journal: Stem cell reports
Published: November 26, 2025
Decellularized Extracellular Matrix Produced by iPSC-Derived MSCs Promotes iPSC-MSC Proliferation and Differentiation and Regulates Secreted Factors.
Journal: Journal of biomedical materials research. Part A
Published: July 07, 2025
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury.
Journal: Stem cell research & therapy
Published: June 22, 2025
Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 03, 2024
Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing.
Journal: NPJ Regenerative medicine
Published: March 09, 2024
Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease.
Journal: Nature medicine
Published: December 09, 2023
Biomaterials directed activation of a cryostable therapeutic secretome in induced pluripotent stem cell derived mesenchymal stromal cells.
Journal: Journal of tissue engineering and regenerative medicine
Published: May 29, 2022
Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease.
Journal: Frontiers in immunology
Published: August 20, 2021
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.
Journal: Nature medicine
Published: February 14, 2020
Last Updated: 09/26/2026